[Federal Register Volume 77, Number 98 (Monday, May 21, 2012)]
[Notices]
[Page 30015]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-12279]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee:
Times and Dates: 8:00 a.m.-5:00 p.m., June 20, 2012, 8:00 a.m.-
1:00 p.m., June 21, 2012.
Place: CDC, Tom Harkin Global Communications Center, 1600
Clifton Road NE., Building 19, Kent ``Oz'' Nelson Auditorium,
Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate uses of immunizing agents. In addition,
under 42 U.S.C. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines. Further, under provisions of the Affordable Care Act,
at section 2713 of the Public Health Service Act, immunization
recommendations of the ACIP that have been adopted by the Director
of the Centers for Disease Control and Prevention must be covered by
applicable health plans.
Matters To Be Discussed: The agenda will include discussions on:
adult immunization, human papillomavirus vaccines, hepatitis B
vaccine, meningococcal vaccines, influenza, pneumococcal vaccines,
measles-mumps-rubella vaccine, pertussis, development of evidence-
based recommendations, Institute of Medicine vaccine committee
report, and anthrax vaccine adsorbed and vaccine supply.
Recommendation votes are scheduled for pneumococcal vaccines and for
influenza. Time will be available for public comment.
Agenda items are subject to change as priorities dictate.
Meeting is webcast live via the World Wide Web; for instructions
and more information on ACIP please visit the ACIP Web site: http://www.cdc.gov/vaccines/recs/acip/.
Contact Person for More Information: Stephanie B. Thomas,
National Center for Immunization and Respiratory Diseases, CDC, 1600
Clifton Road NE., MS-A27, Atlanta, Georgia 30333, Telephone (404)
639-8836; Email [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Dated: May 15, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2012-12279 Filed 5-18-12; 8:45 am]
BILLING CODE 4160-18-P